In addition to these general metabolic changes linking impaired energy production to fatigue as a common symptom between long COVID, ME/CFS and MDD, common differences in specific metabolites may also be of importance
**Gallbladder Disease**: Some studies have found an increased risk of gallbladder problems, including gallstones, in patients taking GLP-1 agonists and dual agonists
Safety profiles vary considerably between different types of weight loss injections, with GLP-1 receptor agonists having well-characterised adverse effect profiles from extensive clinical trials, while lipotropic injections lack comparable safety data
L-Carnitine, in any form, is just 20% of the equation a support tool
Oral formulations such as Rybelsus, which contains semaglutide, offer more comfort but still require careful dosing and often have gastrointestinal side effects